Cancer Diagnostics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Cancer Diagnostics Market

1.1. Definition and Scope

1.1.1. Definition of Cancer Diagnostics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Cancer Diagnostics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Cancer Diagnostics Market By Product

1.2.3. Cancer Diagnostics Market By Type

1.2.4. Cancer Diagnostics Market By Test Type

1.2.5. Cancer Diagnostics Market By Application

1.2.6. Cancer Diagnostics Market By End-Use

1.2.7. Cancer Diagnostics Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Cancer Diagnostics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Cancer Diagnostics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2022

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Cancer Diagnostics Market By Product

4.1. Introduction

4.2. Cancer Diagnostics Revenue By Product

4.2.1. Cancer Diagnostics Revenue (USD Million) and Forecast, By Product, 2020-2032

4.2.2. Instruments

4.2.2.1. Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2. Pathology-Based Instruments

4.2.2.2.1. Pathology-Based Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.2. Slide Staining Systems

4.2.2.2.2.1. Slide Staining Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.3. Tissue Processing Systems

4.2.2.2.3.1. Tissue Processing Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.4. Cell Processors

4.2.2.2.4.1. Cell Processors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.5. PCR Instruments

4.2.2.2.5.1. PCR Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.6. NGS Instruments

4.2.2.2.6.1. NGS Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.7. Microarrays

4.2.2.2.7.1. Microarrays Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.2.8. Other Pathology-based Instruments

4.2.2.2.8.1. Other Pathology-based Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.3. Imaging Instruments

4.2.2.3.1. Imaging Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.2.4. Others

4.2.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3. Consumables

4.2.3.1. Consumables Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.2. Antibodies

4.2.3.2.1. Antibodies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.3. Kits & reagents

4.2.3.3.1. Kits & reagents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.4. Probes

4.2.3.4.1. Probes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.5. Others

4.2.3.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.4. Services

4.2.4.1. Services Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 5. Cancer Diagnostics Market By Type

5.1. Introduction

5.2. Cancer Diagnostics Revenue By Type

5.2.1. Cancer Diagnostics Revenue (USD Million) and Forecast, By Type, 2020-2032

5.2.2. IVD

5.2.2.1. IVD Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2. By Type

5.2.2.2.1. By Type Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2.2. Diagnosis

5.2.2.2.2.1. Diagnosis Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2.3. Early Detection

5.2.2.2.3.1. Early Detection Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2.4. Therapy Selection

5.2.2.2.4.1. Therapy Selection Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2.5. Monitoring

5.2.2.2.5.1. Monitoring Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3. By Technology

5.2.2.3.1. By Technology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.2. Polymerase Chain Reaction (PCR)

5.2.2.3.2.1. Polymerase Chain Reaction (PCR) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.3. In Situ Hybridization (ISH)

5.2.2.3.3.1. In Situ Hybridization (ISH) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.4. Immunohistochemistry (IHC)

5.2.2.3.4.1. Immunohistochemistry (IHC) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.5. Next-generation Sequencing (NGS)

5.2.2.3.5.1. Next-generation Sequencing (NGS) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.6. Microarrays

5.2.2.3.6.1. Microarrays Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.7. Flow Cytometry

5.2.2.3.7.1. Flow Cytometry Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.8. Immunoassays

5.2.2.3.8.1. Immunoassays Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3.9. Other IVD Testing Technologies

5.2.2.3.9.1. Other IVD Testing Technologies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. LDT

5.2.3.1. LDT Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Imaging

5.2.4.1. Imaging Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.1.1. Magnetic Resonance Imaging (MRI)

5.2.4.1.1.1. Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.1.2. Computed Tomography (CT)

5.2.4.1.2.1. Computed Tomography (CT) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.1.3. Positron Emission Tomography (PET)

5.2.4.1.3.1. Positron Emission Tomography (PET) Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.1.4. Mammography

5.2.4.1.4.1. Mammography Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.1.5. Ultrasound

5.2.4.1.5.1. Ultrasound Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.1.6. Others

5.2.4.1.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Cancer Diagnostics Market By Test Type

6.1. Introduction

6.2. Cancer Diagnostics Revenue By Test Type

6.2.1. Cancer Diagnostics Revenue (USD Million) and Forecast, By Test Type, 2020-2032

6.2.2. Biopsy

6.2.2.1. Biopsy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.2. Fine-needle Aspiration

6.2.2.2.1. Fine-needle Aspiration Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.3. Core Biopsy

6.2.2.3.1. Core Biopsy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.4. Surgical Biopsy

6.2.2.4.1. Surgical Biopsy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.5. Skin Biopsy /Punch Biopsy

6.2.2.5.1. Skin Biopsy /Punch Biopsy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.6. Others

6.2.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Others

6.2.3.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Cancer Diagnostics Market By Application

7.1. Introduction

7.2. Cancer Diagnostics Revenue By Application

7.2.1. Cancer Diagnostics Revenue (USD Million) and Forecast, By Application, 2020-2032

7.2.2. Breast Cancer

7.2.2.1. Breast Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Colorectal Cancer

7.2.3.1. Colorectal Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Cervical Cancer

7.2.4.1. Cervical Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Lung Cancer

7.2.5.1. Lung Cancer Companies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.6. Prostate Cancer

7.2.6.1. Prostate Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.7. Skin Cancer

7.2.7.1. Skin Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.8. Blood Cancer

7.2.8.1. Blood Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.9. Kidney Cancer

7.2.9.1. Kidney Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.10. Liver Cancer

7.2.10.1. Liver Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.11. Pancreatic Cancer

7.2.11.1. Pancreatic Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.12. Ovarian Cancer

7.2.12.1. Ovarian Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.13. Others

7.2.13.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 8. Cancer Diagnostics Market By End-Use

8.1. Introduction

8.2. Cancer Diagnostics Revenue By End-Use

8.2.1. Cancer Diagnostics Revenue (USD Million) and Forecast, By End-Use, 2020-2032

8.2.2. Hospitals

8.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.3. Laboratories

8.2.3.1. Laboratories Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.4. Others

8.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 9. North America Cancer Diagnostics Market By Country 

9.1. North America Cancer Diagnostics Market Overview

9.2. U.S.

9.2.1. U.S. Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

9.2.2. U.S. Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

9.2.3. U.S. Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

9.2.4. U.S. Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.5. U.S. Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.3. Canada

9.3.1. Canada Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

9.3.2. Canada Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

9.3.3. Canada Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

9.3.4. Canada Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.5. Canada Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.4. North America PEST Analysis

 

CHAPTER 10. Europe Cancer Diagnostics Market By Country

10.1. Europe Cancer Diagnostics Market Overview

10.2. U.K.

10.2.1. U.K. Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

10.2.2. U.K. Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

10.2.3. U.K. Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.2.4. U.K. Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.5. U.K. Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.3. Germany

10.3.1. Germany Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

10.3.2. Germany Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

10.3.3. Germany Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.3.4. Germany Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.5. Germany Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.4. France

10.4.1. France Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

10.4.2. France Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

10.4.3. France Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.4.4. France Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.5. France Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.5. Spain

10.5.1. Spain Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

10.5.2. Spain Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

10.5.3. Spain Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.5.4. Spain Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.5. Spain Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

10.6.2. Rest of Europe Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

10.6.3. Rest of Europe Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

10.6.4. Rest of Europe Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.5. Rest of Europe Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.7. Europe PEST Analysis

 

CHAPTER 11. Asia Pacific Cancer Diagnostics Market By Country

11.1. Asia Pacific Cancer Diagnostics Market Overview

11.2. China

11.2.1. China Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

11.2.2. China Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

11.2.3. China Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.2.4. China Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.5. China Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.3. Japan

11.3.1. Japan Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

11.3.2. Japan Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

11.3.3. Japan Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.3.4. Japan Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.5. Japan Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.4. India

11.4.1. India Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

11.4.2. India Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

11.4.3. India Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.4.4. India Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.5. India Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.5. Australia

11.5.1. Australia Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

11.5.2. Australia Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

11.5.3. Australia Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.5.4. Australia Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

11.5.5. Australia Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.6. South Korea

11.6.1. South Korea Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

11.6.2. South Korea Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

11.6.3. South Korea Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.6.4. South Korea Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

11.6.5. South Korea Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

11.7.2. Rest of Asia-Pacific Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

11.7.3. Rest of Asia-Pacific Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

11.7.4. Rest of Asia-Pacific Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

11.7.5. Rest of Asia-Pacific Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.8. Asia Pacific PEST Analysis

 

CHAPTER 12. Latin America Cancer Diagnostics Market By Country

12.1. Latin America Cancer Diagnostics Market Overview

12.2. Brazil

12.2.1. Brazil Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

12.2.2. Brazil Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

12.2.3. Brazil Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

12.2.4. Brazil Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.5. Brazil Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.3. Mexico

12.3.1. Mexico Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

12.3.2. Mexico Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

12.3.3. Mexico Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

12.3.4. Mexico Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.5. Mexico Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

12.4.2. Rest of Latin America Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

12.4.3. Rest of Latin America Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

12.4.4. Rest of Latin America Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.5. Rest of Latin America Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.5. Latin America PEST Analysis

 

CHAPTER 13. Middle East & Africa Cancer Diagnostics Market By Country 

13.1. Middle East & Africa Cancer Diagnostics Market Overview

13.2. GCC

13.2.1. GCC Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

13.2.2. GCC Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

13.2.3. GCC Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

13.2.4. GCC Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

13.2.5. GCC Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

13.3. South Africa

13.3.1. South Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

13.3.2. South Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

13.3.3. South Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

13.3.4. South Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

13.3.5. South Africa Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Type, 2020-2032

13.4.2. Rest of Middle East & Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Product, 2020-2032

13.4.3. Rest of Middle East & Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Test Type, 2020-2032

13.4.4. Rest of Middle East & Africa Cancer Diagnostics Revenue (USD Million) and Forecast By Application, 2020-2032

13.4.5. Rest of Middle East & Africa Cancer Diagnostics Revenue (USD Million) and Forecast By End-Use, 2020-2032

13.5. Middle East & Africa PEST Analysis

 

CHAPTER 14. Player Analysis Of Cancer Diagnostics Market

14.1. Cancer Diagnostics Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Cancer Diagnostics Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 15. Company Profile

15.1. Roche Diagnostics

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Million), 2022

15.1.3.2. Roche Diagnostics 2022 Cancer Diagnostics Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Thermo Fisher Scientific, Inc.

15.3. Illumina, Inc.

15.4. Siemens Healthcare

15.5. Agilent Technologies, Inc.

15.6. bioMérieux SA

15.7. QIAGEN N.V.

15.8. Abbott Laboratories, Inc.

15.9. GE Healthcare

15.10. Philips Healthcare

15.11. Becton, and Dickinson and Company